Enzymatically degradable, starch-based layer-by-layer films: application to cytocompatible single-cell nanoencapsulation. Issue 26 (8th June 2020)

• Record Type: Journal Article
• Authors: Moon, Hee Chul; Han, Sol; Borges, João; Pesqueira, Tamagno; Choi, Hyunwoo; Han, Sang Yeong; Cho, Hyeoncheol; Park, Ji Hun; Mano, João F.; Choi, Insung S.
• Is Part Of: Soft matter. Volume 16:Issue 26(2020)
• Page Start: 6063
• Page End: 6071
• Publication Date: 2020-06-08
• Subjects: Soft condensed matter -- Periodicals; 530.413
• DOI: 10.1039/d0sm00876a
• Languages: English
• ISSNs: 1744-683X

Abstract

Abstract : Starch-based layer-by-layer (LbL) nanofilms are formed and enzymatically degraded on individual Saccharomyces cerevisiae in a highly cytocompatible fashion. Their enzymatic degradation by α-amylase is also exploited for the controlled release of DNA. Abstract : The build-up and degradation of cytocompatible nanofilms in a controlled fashion have great potential in biomedical and nanomedicinal fields, including single-cell nanoencapsulation (SCNE). Herein, we report the fabrication of biodegradable films of cationic starch (c-ST) and anionic alginate (ALG) by electrostatically driven layer-by-layer (LbL) assembly technology and its application to the SCNE. The [c-ST/ALG] multilayer nanofilms, assembled either on individual Saccharomyces cerevisiae or on the 2D flat gold surface, degrade on demand, in a cytocompatible fashion, via treatment with α-amylase. Their degradation profiles are investigated, while systematically changing the α-amylase concentration, by several surface characterization techniques, including quartz crystal microbalance with dissipation monitoring (QCM-D) and ellipsometry. DNA incorporation in the LbL nanofilms and its controlled release, upon exposure of the nanofilms to an aqueous α-amylase solution, are demonstrated. The highly cytocompatible nature of the film-forming and -degrading conditions is assessed in the c-ST/ALG-shell formation and degradation of S. cerevisiae . We envisage that the cytocompatible, enzymatic degradation of c-ST-based nanofilms paves the way for developing advanced biomedical devices with programmed dissolution in vivo .